These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 20347499)

  • 21. AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
    Huynh H; Ngo VC; Koong HN; Poon D; Choo SP; Toh HC; Thng CH; Chow P; Ong HS; Chung A; Goh BC; Smith PD; Soo KC
    J Hepatol; 2010 Jan; 52(1):79-87. PubMed ID: 19910069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
    Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
    J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
    Peng J; Mo R; Ma J; Fan J
    World J Surg Oncol; 2015 May; 13():175. PubMed ID: 25951903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
    Tsang WP; Kwok TT
    Apoptosis; 2008 Oct; 13(10):1215-22. PubMed ID: 18758960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
    Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
    Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.
    Cao XX; Mohuiddin I; Ece F; McConkey DJ; Smythe WR
    Am J Respir Cell Mol Biol; 2001 Nov; 25(5):562-8. PubMed ID: 11713097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
    Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
    Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.
    Wakabayashi K; Saito H; Kaneko F; Nakamoto N; Tada S; Hibi T
    Int J Oncol; 2005 Jan; 26(1):233-9. PubMed ID: 15586245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL.
    Zhan M; Qu Q; Wang G; Zhou H
    Pharmazie; 2013 Dec; 68(12):955-61. PubMed ID: 24400442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
    Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of let-7c on the proliferation of human hepatocellular carcinoma cell HCCLM3].
    Gong FX; Xia JL; Yang BW; Xu XJ; Wu WZ
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):853-6. PubMed ID: 22433309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.
    Tsang WP; Kwok TT
    J Nutr Biochem; 2010 Feb; 21(2):140-6. PubMed ID: 19269153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY; Stein CA
    Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
    BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma.
    Galmiche A; Ezzoukhry Z; François C; Louandre C; Sabbagh C; Nguyen-Khac E; Descamps V; Trouillet N; Godin C; Regimbeau JM; Joly JP; Barbare JC; Duverlie G; Mazière JC; Chatelain D
    Mol Cancer Res; 2010 Aug; 8(8):1116-25. PubMed ID: 20647330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
    Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL.
    Emanuele S; D'Anneo A; Bellavia G; Vassallo B; Lauricella M; De Blasio A; Vento R; Tesoriere G
    Eur J Cancer; 2004 Jun; 40(9):1441-52. PubMed ID: 15177505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
    Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
    Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.
    Poma P; Notarbartolo M; Labbozzetta M; Sanguedolce R; Alaimo A; Carina V; Maurici A; Cusimano A; Cervello M; D'Alessandro N
    Int J Oncol; 2006 Apr; 28(4):923-30. PubMed ID: 16525642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.